Analyst Conference Summaries

Biotechnology Investor Aids

Avidity Biosciences
RNA

conference date: May 12, 2021 (press relase only)

Avidity Biosciences Has A Promising RNA Therapy Platform [January 12, 2020 at Seeking Alpha]

2021
Avidity
Biosciences
Q4 2020
Avidity
Biosciences
Q1 2021
Avidity
Biosciences
Q2 2021
Press Release Only
 
March 16, 2021 May 12, 2021 August 9, 2021  

Avidity Biosciences (RNA) is a preclinical-stage biotechnology company specializing in a novel RNA therapy platform for diseases caused by genetic mutations.

Avidity Biosciences web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 SAGE
 SGEN
 VBLT
 VSTM
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers